Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ContextLogic Inc. - Class A Common Stock (NQ: LOGC ) 5.350 +0.030 (+0.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about ContextLogic Inc. - Class A Common Stock < Previous 1 2 3 Next > LogicBio Therapeutics: Q1 Earnings Insights May 16, 2022 LogicBio Therapeutics (NASDAQ:LOGC) reported its Q1 earnings results on Monday, May 16, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 10, 2022 Via Benzinga 77 Stocks Moving In Tuesday's Mid-Day Session May 10, 2022 Gainers Via Benzinga LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial May 09, 2022 Via Benzinga 103 Biggest Movers From Yesterday May 11, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 10, 2022 Via Benzinga 30 Stocks Moving in Tuesday's Pre-Market Session May 10, 2022 Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 09, 2022 Via Benzinga Why LogicBio Therapeutics Shares Are Popping Off Today May 09, 2022 LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher by 63.48% at $0.81 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application,... Via Benzinga 90 Biggest Movers From Yesterday May 10, 2022 Gainers Via Benzinga FDA Lifts Clinical Hold on LogicBio Therapeutics' IND for LB-001 in pediatric patients with Methylmalonic Acidemia May 09, 2022 The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on LogicBio Therapeutics’ (NASDAQ: LOGC) Investigational New Drug Application (IND) of its drug candidate LB-001 for pediatric... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 09, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 06, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 02, 2022 Via Benzinga 80 Biggest Movers From Yesterday May 04, 2022 Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 29, 2022 Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday! Via InvestorPlace 71 Biggest Movers From Yesterday April 27, 2022 Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga LogicBio Therapeutics's Return On Capital Employed Insights March 10, 2022 According to Benzinga Pro data, during Q4, LogicBio Therapeutics (NASDAQ:LOGC) posted sales of $2.03 million. Earnings were up 11.02%, but LogicBio Therapeutics still reported an... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 28, 2022 Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5... Via Benzinga The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More February 06, 2022 Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came... Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022 February 03, 2022 Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago... Via Benzinga The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More February 06, 2022 Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... Via Benzinga Analyst Ratings For LogicBio Therapeutics February 02, 2022 Over the past 3 months, 4 analysts have published their opinion on LogicBio Therapeutics (NASDAQ:LOGC) stock. These analysts are typically employed by large Wall Street banks and tasked with... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday February 02, 2022 During Wednesday's session, 18 companies made new 52-week lows. Noteable 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) is the largest company in terms of market... Via Benzinga 54 Biggest Movers From Yesterday February 03, 2022 Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 02, 2022 Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6... Via Benzinga Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today? February 02, 2022 The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with methylmalonic... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 02, 2022 Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million.... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday February 02, 2022 Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! Via InvestorPlace < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.